Craniofacial clefts are rare among facial anomalies, with an incidence of 1.5 to 5 per 100,000 births, and 1 per 100 cases of cleft lip and palate. The Tessier No. 4 oro-ocular cleft is one of the rarest, with 33 unilateral and bilateral clefts reported in the literature. Among the bilateral clefts only 3 of 9 involved Tessier No. 4 cleft bilaterally. We report a case of bilateral Tessier No. 4 craniofacial cleft and our approach to surgical correction.
We present the case of an 8-month-old infant who was admitted to our Neurosurgery Department with venous infarction related to sagittal sinus thrombosis. The infarction was radiologically detected 5 days after the baby had undergone surgery for acute subdural hematoma due to a closed head injury. Cerebrovascular venous thrombosis is a rare clinical entity that has multiple causes and variable presenting symptoms. There is no consensus on overall strategy concerning surgical, radiosurgical, or medical therapy (anti-coagulation, thrombolytic, and anti-edema treatment), and exactly how, when, or in which cases these should be applied. The treatment planning should be based on clinical findings, and should be modified according to the clinical course. In this case, the clinical and radiological findings regressed with symptomatic treatment alone.
Introduction: Obesity and metabolic syndrome are universal health problems. There is increasing evidence that vitamin D deficiency is a risk factor in the development of insulin resistance(IR). This study was aimed to investigate the relationship between vitamin D level and IR in obese patients. Method: The study included 95 adult, obese patients, without a history of hypertension, diabetes mellitus, and hyperlipidemia. Fasting blood glucose, insulin, 25-OH-vitamin D, and serum lipid levels were measured and the HOMA-IR level was calculated. The patients were divided into 3 groups according to their obesity level. Results: Seventy-eight (82.1%) of patients were female and vitamin D deficiency was found in 77.9% of the patients. The median HOMA-IR level of the group with and without vitamin D deficiency was 3.57, and 2.39, respectively (p = 0.029). There weren't any significant differences in gender, BMI, and vitamin D levels between the groups with /without IR. No difference was found between obesity level groups in terms of age, gender, and vitamin D level. However, while insulin level and IR level increased significantly in morbid obese patients, this relationship could not be demonstrated in super-obese patients. Conclusion: This study is the first study investigating the relationship between vitamin D-HOMA-IR in morbid and super obese patients. No statistically significant linear correlation was found between vitamin D and HOMA-IR level, but vitamin D deficiency was more common in the group with IR. Additional studies are needed to explain the relationship between the level of obesity and the effect of vitamin D on IR.
Aims: Peritoneal dialysis (PD) is an effective renal replacement therapy; however, technique failure and treatment discontinuation remain major challenges. Identifying modifiable clinical and biological risk factors is essential to improve PD continuity.Methods: This single-center retrospective cohort study included 96 adult PD patients followed between January 2018 and September 2025. Patients were classified into PD continuation and dropout groups, with dropout defined as transition to hemodialysis, mortality, or permanent cessation of PD. Inflammatory indices including systemic immune-inflammation index (SII), systemic inflammation response index (SIRI), and C-reactive protein-albumin-lymphocyte (CALLY) index were calculated. Comparative analyses were performed, and multivariate logistic regression was used to identify independent predictors.Results: Among 96 patients, 54 continued PD and 31 discontinued treatment. Peritonitis was significantly more frequent in the dropout group, particularly ≥2 episodes (p=0.014). Inflammatory markers were markedly elevated in the dropout group (CRP, SII, SIRI; p